Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-06

Clinical Trial Update: Bivalirudin with Prolonged Infusion During PCI Versus Heparin After Fibrinolytic Therapy [NA]

View source ↗

Summary

A clinical trial comparing bivalirudin with prolonged infusion during PCI versus heparin after fibrinolytic therapy in ST-segment Elevation Myocardial Infarctio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Angiomax (bivalirudin)
  • Heparin (unfractionated heparin)

Snippet

Sponsor: First Affiliated Hospital Xi'an Jiaotong University | Conditions: ST-segment Elevation Myocardial Infarction (STEMI) | NA | Status: NOT_YET_RECRUITING